Hey mega,with excellent trial data , indicating the possibility of the Keytruda/Efti combo potentially becoming a chemo free option of standard of care, with excellent safety and durability in the largest cancer indication,you would have to imagine Immutep would be high on Mercks radar.
Media, page-605
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
-0.036(8.07%) |
Mkt cap ! $487.4M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 42.0¢ | 40.0¢ | $5.882M | 14.30M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15669 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 181138 | 2 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
41.0¢ |
Change
-0.036 ( 6.03 %) |
||||
| Open | High | Low | Volume | ||
| 40.5¢ | 42.5¢ | 40.0¢ | 4798735 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| IMM (ASX) Chart |